VICARIOUS SURGICAL INC. Payments to Acquire Debt Securities, Available-for-sale
VICARIOUS SURGICAL INC. (RBOT) reported Payments to Acquire Debt Securities, Available-for-sale of $21.34 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-03-09
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $6.38M, a 18.88% increase year-over-year.
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $3.95M, a 71.58% decline year-over-year.
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-06-30 was $2.08M, a 89.27% decline year-over-year.
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-03-31 was $8.93M, a 54.18% decline year-over-year.
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $21.34M, a 63.30% decline from fiscal 2024.
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $58.15M, a 23.19% decline from fiscal 2023.
- VICARIOUS SURGICAL INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $75.70M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $10.33M derived: sum of 2 quarters · filed 2026-03-09 | $12.41M derived: sum of 3 quarters · filed 2026-03-09 | $21.34M 10-K · filed 2026-03-09 |
| 2025-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $6.03M derived: sum of 2 quarters · filed 2025-11-12 | $14.96M 10-Q · filed 2025-11-12 | $20.33M derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $11.01M 10-Q · filed 2025-08-12 | $16.38M derived: sum of 3 quarters · filed 2026-03-09 | $30.27M derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $8.93M 10-Q · filed 2025-05-12 | $14.30M derived: sum of 2 quarters · filed 2026-03-09 | $28.19M derived: sum of 3 quarters · filed 2026-03-09 | $47.59M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $19.26M derived: sum of 2 quarters · filed 2026-03-09 | $38.66M derived: sum of 3 quarters · filed 2026-03-09 | $58.15M 10-K · filed 2026-03-09 |
| 2024-09-30 | $13.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $33.29M derived: sum of 2 quarters · filed 2025-11-12 | $52.78M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $19.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $38.89M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $19.49M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $75.70M 10-K · filed 2025-03-17 |